In summary, our research indicated the critical role of ACTRIIB's N-glycosylation in the proliferation and invasion of NPC cells and revealed a new mechanism by which inhibiting this modification process may enhance chemosensitivity. Here, ACVR2B is linked to nasopharyngeal carcinoma.